Cargando…

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

OBJECTIVES: To analyze the patterns and risk factors of HIV drug resistance mutations among patients failing second-line treatment and to describe early treatment responses to recommended third-line antiretroviral therapy (ART) in a national referral HIV clinic in Zimbabwe. METHODS: Patients on boos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chimbetete, Cleophas, Katzenstein, David, Shamu, Tinei, Spoerri, Adrian, Estill, Janne, Egger, Matthias, Keiser, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801603/ https://www.ncbi.nlm.nih.gov/pubmed/29435471 http://dx.doi.org/10.1093/ofid/ofy005

Ejemplares similares

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Cancer incidence among people living with HIV in Zimbabwe: A record linkage study
por: Shamu, Tinei, et al.
Publicado: (2021)

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
por: Shawarira-Bote, Sandra, et al.
Publicado: (2019)

Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

A4 Development of HIV drug resistance in HIV-infected patients failing second line regimen in Zimbabwe: A public health concern
por: Kouamou, V, et al.
Publicado: (2018)

Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study
por: Shamu, Tinei, et al.
Publicado: (2021)

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
por: Kasimonje, Bahati, et al.
Publicado: (2021)

Profile of elderly patients receiving antiretroviral therapy at Newlands Clinic in 2020: A cross-sectional study
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Comparison of predictors for early and late mortality in adults commencing HIV antiretroviral therapy in Zimbabwe: a retrospective cohort study
por: Byers, Bradley W., et al.
Publicado: (2022)

Outcomes of an HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, Zimbabwe: TENART cohort
por: Shamu, Tinei, et al.
Publicado: (2017)

Sexually transmitted infections, the silent partner in HIV-infected women in Zimbabwe
por: Lowe, Sara, et al.
Publicado: (2019)

Cervical Cancer Screening Cascade for women living with HIV: A cohort study from Zimbabwe
por: Taghavi, Katayoun, et al.
Publicado: (2022)

Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study
por: Mudzviti, Tinashe, et al.
Publicado: (2019)

A case report of untreatable HIV infection in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2019)

Comparison of CG, CKD-EPI[AS] and CKD-EPI[ASR] equations to estimate glomerular filtration rate and predict mortality in treatment naïve people living with HIV in Zimbabwe
por: Hunter-Dickson, Mitchell, et al.
Publicado: (2023)

Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis
por: Chihota, Belinda V., et al.
Publicado: (2022)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
por: Sovershaeva, Evgeniya, et al.
Publicado: (2019)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

The Cost-Effectiveness of Monitoring Strategies for Antiretroviral Therapy of HIV Infected Patients in Resource-Limited Settings: Software Tool
por: Estill, Janne, et al.
Publicado: (2015)

The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical Model
por: Estill, Janne, et al.
Publicado: (2018)

Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review
por: Mugglin, Catrina, et al.
Publicado: (2013)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 Subtypes
por: Huang, Austin, et al.
Publicado: (2015)

Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe
por: Mandiriri, Ardele M., et al.
Publicado: (2020)

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
por: Zhao, Ying, et al.
Publicado: (2023)

Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program
por: Haas, Andreas D., et al.
Publicado: (2016)

Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe
por: Mapangisana, Tichaona, et al.
Publicado: (2021)

The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania
por: Ramadhani, Habib O., et al.
Publicado: (2016)

Detection of HIV Virologic Failure and Switch to Second-Line Therapy: A Systematic Review and Meta-analysis of Data From Sub-Saharan Africa
por: Bernabé, Kerlly J, et al.
Publicado: (2022)

Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study
por: Mugglin, Catrina, et al.
Publicado: (2019)

Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis
por: Jannone, Giulia, et al.
Publicado: (2022)

Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria
por: Rawizza, Holly E., et al.
Publicado: (2013)

Socioeconomic inequalities in cervical precancer screening among women in Ethiopia, Malawi, Rwanda, Tanzania, Zambia and Zimbabwe: analysis of Population-Based HIV Impact Assessment surveys
por: Chipanta, David, et al.
Publicado: (2023)

Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial
por: Kouamou, Vinie, et al.
Publicado: (2023)

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia
por: Jordan, Michael R., et al.
Publicado: (2020)

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy
por: Cohe, Karen, et al.
Publicado: (2019)

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
por: Ko, J J, et al.
Publicado: (2014)

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial
por: Bevers, Lisanne A H, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tshant6asvsltafvvg2e4f1ab7